BIIB News and Press, Biogen Inc. From 06/12/24

2024-06-12 14:20:26 ET Biogen Inc. (BIIB) Goldman Sachs 45th Annual Global Healthcare Conference June 12, 2024, 10:40 AM ET Company Participants Alisha Alaimo - Head and President of North-America Chuck Triano - Head of IR Conference Call Participants Sal...

2024-06-12 12:30:03 ET Scotiabank analyst issues SECTOR OUTPERFORM recommendation for BIIB on June 12, 2024 10:10AM ET. The previous analyst recommendation was Sector Outperform. BIIB was trading at $230.28 at issue of the analyst recommendation. The overall analyst cons...

2024-06-12 12:00:07 ET George Farmer from Scotiabank issued a price target of $275.00 for BIIB on 2024-06-12 10:10:00. The adjusted price target was set to $275.00. At the time of the announcement, BIIB was trading at $230.28. The overall price target consensus is at $29...

2024-06-12 06:10:00 ET Summary The Morningstar Wide Moat Focus Index ended May, trailing the S&P 500 Index by nearly 9% thus far in 2024. The S&P 500 Equal Weighted Index is now trading at levels relative to the market cap-weighted S&P 500 Index that haven’t bee...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Biogen To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - June 11, 2024) - Faruqi & Faruqi, LLP, a leading national se...

2024-06-11 08:45:53 ET Palm Beach, FL – June 11, 2024 – FN Media Group News Commentary – In the last twenty years, the amount of people with multiple sclerosis (MS) in the United States has more than doubled. In 2000, it was estimated by the National Multipl...

New York, New York--(Newsfile Corp. - June 10, 2024) - Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (NASDAQ: BIIB) Securities Class Action Lawsuit. If you invested in Biogen, you are encouraged to obtain additional information b...

2024-06-10 12:09:47 ET More on Biogen, Eisai , etc. Biogen Inc. (BIIB) Q1 2024 Earnings Call Transcript Eisai Co Ltd. (ESALF) Q4 2024 Earnings Call Transcript Biogen: Reasons To Be Cheerful After Upbeat Q1 Earnings Lilly's donanemab, remternetug set to d...

NEW YORK, NY / ACCESSWIRE / June 10, 2024 / Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq:BIIB) Securities Class Action Lawsuit. If you invested in Biogen, you are encouraged to obtain additional information by visiting ...

FDA Accepts Eisai's Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease PR Newswire TOKYO and CAMBRIDGE, Mass. , June 9, 2024 /PRNewswire/ -- Eisai C...